Navigation Links
Triple negative breast cancer symposium highlights current advances
Date:4/27/2012

The 5th Annual Jean Sindab Triple Negative Breast Cancer Symposium, sponsored by the Winship Cancer Institute at Emory University, provides an intimate learning environment in which the most current advances in triple-negative breast cancers (TNBC) will be explored. Nationally recognized speakers will review research, clinical experiences, and provide updates on current research in TNBC. TNBC affects young women and African American women disproportionately. TNBC has no targeted therapies and chemotherapy is effective only in a minority of cases. This symposium increases awareness of TNBC and focuses on current, ongoing research to improve outcomes for patients with this disease.

Target Audience

This live activity is designed for medical oncologists, radiation oncologists, surgical oncologists, radiologists, pathologists, and other healthcare providers involved with or interested in the diagnosis, treatment, and management of breast cancer.

Educational Objectives

At the conclusion of the conference, the attendees should be able to:

  • Update adjuvant and neo-adjuvant approaches for treating patients with TNBC

  • Discuss different pathologic subtypes of TNBC

  • Update novel therapeutic approaches for metastatic TNBC

  • Discuss local therapeutic approaches for TNBC

  • Discuss molecular subtyping of TNBC

  • Discuss IGF1R signaling in TNBC

  • Discuss the role of DNA repair defects in TNBC

  • Discuss issues, including fatigue, in breast cancer survivors

Core Competencies: Patient Care and Medical Knowledge

Continuing Medical Education:

The Emory University School of Medicine designates this live activity for a maximum of 7 AMA Physicians Recognition Award Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.


'/>"/>
Contact: Trish Campbell
psnicho@emory.edu
404-788-2218
Emory University
Source:Eurekalert

Page: 1

Related medicine news :

1. Breaking the backbone of triple-negative breast cancers
2. Deaths triple among football players, morning temperatures thought to play a role
3. Injuries to Pedestrians Wearing Headphones Tripled Since 2004
4. SABCS: Loss of RB in triple negative breast cancer associated with favorable clinical outcome
5. First genome sequencing clinical trial for triple negative cancer points to new treatments
6. First whole-genome sequencing clinical trials for triple-negative breast cancer presented
7. Deaths From Abuse of Painkillers Triple in a Decade: CDC
8. Cases of Legionnaires Disease Tripled in 10 Years
9. Triple therapy regime puts patients with leukemic form of cutaneous lymphoma in remission
10. Different subtypes of triple-negative breast cancer respond to different therapies
11. Treatment for Abuse of Anti-Anxiety Drugs Tripled Over 10 Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... Next week ... will be repealed by Congressional political games that circumvent health needs of over 30 ... Rally” capture the human anxieties and needs government public servants were suppose to prioritize. ...
(Date:1/19/2017)... ... 19, 2017 , ... This month, the CEO and Clinical Director of Sober ... rehab center in Delray Beach, Florida has been changed from Sober Living Outpatient to ... Philip Seymour Hoffman and Chris Farley are dying from heroin overdoses, but thousands of ...
(Date:1/19/2017)... ... January 19, 2017 , ... Remote Medical Technologies (RMT), ... transportable capabilities with their iMedHD2™ Portable Teleultrasound System. Compatible with ... that delivers HD, dynamic, streaming ultrasound images and video to one or more ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... Gattefossé, the leader in innovative excipients and drug delivery solutions to health industries ...
(Date:1/19/2017)... ... January 19, 2017 , ... Bio-Optronics Inc. is proud to ... workflow designed to seamlessly integrate and streamline the way researchers prepare and conduct ... maximizing usability and improving efficiency significantly for users – a first in the ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 2017  Sensus Healthcare, Inc. (NASDAQ: ... the treatment of non-melanoma skin cancers and other ... therapy, today announced that it will report its ... on Thursday, February 2, 2017 after the market close. ... call with the investment community on Thursday, February 2, ...
(Date:1/19/2017)... January 19, 2017 New ... to Address Motor Symptoms and Motor Complications in ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) C ... European Neurological Review,2016;11(Suppl. 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late ...
(Date:1/19/2017)... 2017 The Global Therapy Partnering Terms and ... partnering deals and agreements entered into by the world,s ... - Top deals by value - Deals listed by ... The report provides understanding and access to the ... leading healthcare companies. The report provides an analysis ...
Breaking Medicine Technology: